• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估接受全身治疗的多发性骨髓瘤患者反应的非增强全身MRI图像数据的扩展纹理分析

Extended Texture Analysis of Non-Enhanced Whole-Body MRI Image Data for Response Assessment in Multiple Myeloma Patients Undergoing Systemic Therapy.

作者信息

Ekert Kaspar, Hinterleitner Clemens, Baumgartner Karolin, Fritz Jan, Horger Marius

机构信息

Department of Radiology, Diagnostic and Interventional Radiology, Eberhard Karls University, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany.

Department of Internal Medicine II, Eberhard-Karls-University, Otfried-Müller-Str. 10, 72076 Tübingen, Germany.

出版信息

Cancers (Basel). 2020 Mar 24;12(3):761. doi: 10.3390/cancers12030761.

DOI:10.3390/cancers12030761
PMID:32213834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7140042/
Abstract

Identifying MRI-based radiomics features capable to assess response to systemic treatment in multiple myeloma (MM) patients. Retrospective analysis of whole-body MR-image data in 67 consecutive stage III MM patients (40 men; mean age, 60.4 years). Bone marrow involvement was evaluated using a standardized MR-imaging protocol consisting of T1w-, short-tau inversion recovery- (STIR-) and diffusion-weighted-imaging (DWI) sequences. Ninety-two radiomics features were evaluated, both in focally and diffusely involved bone marrow. Volumes of interest (VOI) were used. Response to treatment was classified according to International Myeloma Working Group (IMWG) criteria in complete response (CR), very-good and/or partial response (VGPR + PR), and non-response (stable disease (SD) and progressive disease (PD)). According to the IMWG-criteria, response categories were CR ( = 35), VGPR + PR ( = 19), and non-responders ( = 13). On apparent diffusion coefficient (ADC)-maps, gray-level small size matrix small area emphasis (Gray Level Size Zone (GLSZM) small area emphasis (SAE)) significantly correlated with CR ( < 0.001), whereas GLSZM non-uniformity normalized (NUN) significantly ( < 0.008) with VGPR/PR in focal medullary lesions (FL), whereas in diffuse involvement, 1st order root mean squared significantly ( < 0.001) correlated with CR, whereas for VGPR/PR Log (gray-level run-length matrix (GLRLM) Short Run High Gray Level Emphasis) proved significant ( < 0.003). On T1w, GLRLM NUN significantly ( < 0.002) correlated with CR in FL, whereas gray-level co-occurrence matric (GLCM) informational measure of correlation (Imc1) significantly ( < 0.04) correlated with VGPR/PR. For diffuse myeloma involvement, neighboring gray-tone difference matrix (NGTDM) contrast and 1st order skewness were significantly associated with CR and VGPR/PR ( < 0.001 for both). On STIR-images, CR correlated with gray-level co-occurrence matrix (GLCM) Informational Measure of Correlation (IMC) 1 ( < 0.001) in FL and 1st order mean absolute deviation in diffusely involved bone marrow ( < 0.001). VGPR/PR correlated at best in FL with GSZLM size zone NUN ( < 0.019) and in all other involved medullary areas with GLSZM large area low gray level emphasis ( < 0.001). GLSZM large area low gray level emphasis also significantly correlated with the degree of bone marrow infiltration assessed histologically ( = 0.006). GLCM IMC 1 proved significant throughout T1w/STIR sequences, whereas GLSZM NUN in STIR and ADC. MRI-based texture features proved significant to assess clinical and hematological response (CR, VPGR, and PR) in multiple myeloma patients undergoing systemic treatment.

摘要

识别基于MRI的放射组学特征,以评估多发性骨髓瘤(MM)患者对全身治疗的反应。对67例连续的III期MM患者(40例男性;平均年龄60.4岁)的全身MR图像数据进行回顾性分析。使用由T1加权、短tau反转恢复(STIR)和扩散加权成像(DWI)序列组成的标准化MR成像方案评估骨髓受累情况。评估了92个放射组学特征,包括局灶性和弥漫性受累骨髓。使用感兴趣体积(VOI)。根据国际骨髓瘤工作组(IMWG)标准将治疗反应分为完全缓解(CR)、非常好和/或部分缓解(VGPR + PR)以及无反应(稳定疾病(SD)和进展性疾病(PD))。根据IMWG标准,反应类别为CR(n = 35)、VGPR + PR(n = 19)和无反应者(n = 13)。在表观扩散系数(ADC)图上,灰度小尺寸矩阵小面积强调(灰度级大小区域(GLSZM)小面积强调(SAE))与CR显著相关(P < 0.001),而在局灶性髓质病变(FL)中,GLSZM归一化非均匀性(NUN)与VGPR/PR显著相关(P < 0.008),而在弥漫性受累中,一阶均方根与CR显著相关(P < 0.001),而对于VGPR/PR,Log(灰度级游程长度矩阵(GLRLM)短游程高灰度级强调)被证明具有显著性(P < 0.003)。在T1加权像上,GLRLM NUN在FL中与CR显著相关(P < 0.002),而灰度级共生矩阵(GLCM)相关信息测度(Imc1)与VGPR/PR显著相关(P < 0.04)。对于弥漫性骨髓瘤受累,相邻灰度色调差异矩阵(NGTDM)对比度和一阶偏度与CR和VGPR/PR均显著相关(两者P均 < 0.001)。在STIR图像上,CR在FL中与灰度级共生矩阵(GLCM)相关信息测度(IMC)1显著相关(P < 0.001),在弥漫性受累骨髓中与一阶平均绝对偏差显著相关(P < 0.001)。VGPR/PR在FL中与GSZLM大小区域NUN相关性最佳(P < 0.019),在所有其他受累髓质区域与GLSZM大面积低灰度级强调显著相关(P < 0.001)。GLSZM大面积低灰度级强调也与组织学评估的骨髓浸润程度显著相关(P = 0.006)。GLCM IMC 1在整个T1加权/STIR序列中均被证明具有显著性,而GLSZM NUN在STIR和ADC中具有显著性。基于MRI的纹理特征被证明对于评估接受全身治疗的多发性骨髓瘤患者的临床和血液学反应(CR、VPGR和PR)具有显著性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/83f041b87830/cancers-12-00761-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/026fde040497/cancers-12-00761-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/7fa8d8c74592/cancers-12-00761-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/569b57c0ec4d/cancers-12-00761-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/32ff2521764b/cancers-12-00761-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/4959341069ae/cancers-12-00761-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/d1546a84a7e6/cancers-12-00761-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/83f041b87830/cancers-12-00761-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/026fde040497/cancers-12-00761-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/7fa8d8c74592/cancers-12-00761-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/569b57c0ec4d/cancers-12-00761-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/32ff2521764b/cancers-12-00761-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/4959341069ae/cancers-12-00761-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/d1546a84a7e6/cancers-12-00761-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a3/7140042/83f041b87830/cancers-12-00761-g007.jpg

相似文献

1
Extended Texture Analysis of Non-Enhanced Whole-Body MRI Image Data for Response Assessment in Multiple Myeloma Patients Undergoing Systemic Therapy.用于评估接受全身治疗的多发性骨髓瘤患者反应的非增强全身MRI图像数据的扩展纹理分析
Cancers (Basel). 2020 Mar 24;12(3):761. doi: 10.3390/cancers12030761.
2
Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma.用于监测多发性骨髓瘤患者脊柱纵向受累情况的定性和定量CT及MRI参数比较
Skeletal Radiol. 2018 Mar;47(3):351-361. doi: 10.1007/s00256-017-2827-y. Epub 2017 Dec 8.
3
Mid-term response assessment in multiple myeloma using a texture analysis approach on dual energy-CT-derived bone marrow images - A proof of principle study.基于双能 CT 骨髓图像纹理分析的多发性骨髓瘤中期疗效评估 - 一项原理验证研究。
Eur J Radiol. 2020 Oct;131:109214. doi: 10.1016/j.ejrad.2020.109214. Epub 2020 Aug 15.
4
Longitudinal monitoring of apparent diffusion coefficient (ADC) in myeloma patients with lower M-gradient levels undergoing systemic treatment and whole-body MRI monitoring.对行全身 MRI 监测及系统性治疗且 M 梯度水平较低的骨髓瘤患者行表观扩散系数(ADC)的纵向监测。
Eur J Radiol. 2020 Nov;132:109306. doi: 10.1016/j.ejrad.2020.109306. Epub 2020 Sep 28.
5
Quantitative accuracy of radiomic features of low-dose F-FDG PET imaging.低剂量F-FDG PET成像的放射组学特征的定量准确性
Transl Cancer Res. 2020 Aug;9(8):4646-4655. doi: 10.21037/tcr-20-1715.
6
Prediction of treatment response to transarterial radioembolization of liver metastases: Radiomics analysis of pre-treatment cone-beam CT: A proof of concept study.肝转移瘤经动脉放射性栓塞治疗反应的预测:治疗前锥形束CT的影像组学分析:一项概念验证研究
Eur J Radiol Open. 2021 Aug 30;8:100375. doi: 10.1016/j.ejro.2021.100375. eCollection 2021.
7
Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging.基于全身扩散加权磁共振成像的总肿瘤表观扩散系数直方图分析在多发性骨髓瘤治疗反应评估中的应用。
J Magn Reson Imaging. 2024 Sep;60(3):1051-1060. doi: 10.1002/jmri.29155. Epub 2023 Dec 13.
8
Magnetic resonance imaging-based radiomics analysis of the differential diagnosis of ovarian clear cell carcinoma and endometrioid carcinoma: a retrospective study.基于磁共振成像的影像组学分析在卵巢透明细胞癌与子宫内膜样癌鉴别诊断中的应用:一项回顾性研究。
Jpn J Radiol. 2024 Jul;42(7):731-743. doi: 10.1007/s11604-024-01545-z. Epub 2024 Mar 12.
9
Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.多发性骨髓瘤 MRI 早期治疗反应评估:全身弥散加权和腰椎 MRI 的对比研究。
PLoS One. 2020 Feb 27;15(2):e0229607. doi: 10.1371/journal.pone.0229607. eCollection 2020.
10
Role of computed tomography texture analysis using dual-energy-based bone marrow imaging for multiple myeloma characterization: comparison with histology and established serologic parameters.基于双能骨质成像的 CT 纹理分析在多发性骨髓瘤特征描述中的作用:与组织学和已建立的血清学参数的比较。
Eur Radiol. 2021 Apr;31(4):2357-2367. doi: 10.1007/s00330-020-07320-8. Epub 2020 Oct 3.

引用本文的文献

1
Radiomics model based on MRI to differentiate spinal multiple myeloma from metastases: A two-center study.基于磁共振成像的影像组学模型鉴别脊柱多发性骨髓瘤与转移瘤:一项双中心研究
J Bone Oncol. 2024 Mar 28;45:100599. doi: 10.1016/j.jbo.2024.100599. eCollection 2024 Apr.
2
Imaging of Multiple Myeloma: Present and Future.多发性骨髓瘤的影像学:现状与未来。
J Clin Med. 2024 Jan 2;13(1):264. doi: 10.3390/jcm13010264.
3
Quantitative assessment of bone marrow infiltration and characterization of tumor burden using dual-layer spectral CT in patients with multiple myeloma.

本文引用的文献

1
MRI-derived radiomics: methodology and clinical applications in the field of pelvic oncology.MRI 衍生的放射组学:在骨盆肿瘤领域的方法学和临床应用。
Br J Radiol. 2019 Dec;92(1104):20190105. doi: 10.1259/bjr.20190105. Epub 2019 Oct 10.
2
Texture analysis parameters derived from T1-and T2-weighted magnetic resonance images can reflect Ki67 index in soft tissue sarcoma.基于 T1 加权和 T2 加权磁共振图像的纹理分析参数可反映软组织肉瘤的 Ki67 指数。
Surg Oncol. 2019 Sep;30:92-97. doi: 10.1016/j.suronc.2019.06.006. Epub 2019 Jun 22.
3
MRI Texture Analysis for Differentiating Nonfunctional Pancreatic Neuroendocrine Neoplasms From Solid Pseudopapillary Neoplasms of the Pancreas.
采用双层光谱 CT 对多发性骨髓瘤患者骨髓浸润进行定量评估及肿瘤负荷特征分析。
Radiol Oncol. 2024 Jan 6;58(1):43-50. doi: 10.2478/raon-2024-0003. eCollection 2024 Mar 1.
4
Application of a Radiomics Machine Learning Model for Differentiating Aldosterone-Producing Adenoma from Non-Functioning Adrenal Adenoma.一种用于区分醛固酮瘤与无功能肾上腺腺瘤的影像组学机器学习模型的应用
Bioengineering (Basel). 2023 Dec 14;10(12):1423. doi: 10.3390/bioengineering10121423.
5
MRI radiomics-based evaluation of tuberculous and brucella spondylitis.基于 MRI 影像组学的结核性和布鲁氏菌性脊柱炎评估。
J Int Med Res. 2023 Aug;51(8):3000605231195156. doi: 10.1177/03000605231195156.
6
Development and validation of a contrast-enhanced CT-based radiomics nomogram for differentiating mass-like thymic hyperplasia and low-risk thymoma.基于增强 CT 的影像组学列线图模型的建立与验证:用于鉴别肿块样胸腺增生与低危胸腺瘤。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14901-14910. doi: 10.1007/s00432-023-05263-3. Epub 2023 Aug 21.
7
Radiomics Analysis for Multiple Myeloma: A Systematic Review with Radiomics Quality Scoring.多发性骨髓瘤的放射组学分析:一项采用放射组学质量评分的系统评价
Diagnostics (Basel). 2023 Jun 10;13(12):2021. doi: 10.3390/diagnostics13122021.
8
Machine Learning Model Based on Optimized Radiomics Feature from F-FDG-PET/CT and Clinical Characteristics Predicts Prognosis of Multiple Myeloma: A Preliminary Study.基于F-FDG-PET/CT优化影像组学特征和临床特征的机器学习模型预测多发性骨髓瘤预后:一项初步研究
J Clin Med. 2023 Mar 15;12(6):2280. doi: 10.3390/jcm12062280.
9
Lumbar MR-based radiomics nomogram for detecting minimal residual disease in patients with multiple myeloma.基于腰椎磁共振成像的影像组学列线图用于检测多发性骨髓瘤患者的微小残留病
Eur Radiol. 2023 Aug;33(8):5594-5605. doi: 10.1007/s00330-023-09540-0. Epub 2023 Mar 28.
10
Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy.基于影像组学的列线图作为接受放疗的门静脉癌栓肝细胞癌预后的预测模型。
Front Oncol. 2022 Sep 20;12:906498. doi: 10.3389/fonc.2022.906498. eCollection 2022.
MRI 纹理分析用于鉴别胰腺无功能性神经内分泌肿瘤与胰腺实性假乳头状肿瘤。
Acad Radiol. 2020 Jun;27(6):815-823. doi: 10.1016/j.acra.2019.07.012. Epub 2019 Aug 20.
4
Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.全身磁共振成像的观察者间一致性优于全身计算机断层扫描,可用于评估多发性骨髓瘤患者的疾病负担。
Eur Radiol. 2020 Jan;30(1):320-327. doi: 10.1007/s00330-019-06281-x. Epub 2019 Jul 2.
5
Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosis.利用 RSF 和 PET 图像对多发性骨髓瘤进行诊断预后。
Int J Comput Assist Radiol Surg. 2020 Jan;15(1):129-139. doi: 10.1007/s11548-019-02015-y. Epub 2019 Jun 29.
6
Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.全身磁共振弥散成像(WB-MRI-DWI)在多发性骨髓瘤和淋巴瘤中的肿瘤成像的现代概念。
Leuk Lymphoma. 2018 Nov;59(11):2546-2556. doi: 10.1080/10428194.2018.1434881. Epub 2018 Feb 12.
7
Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.使用全身扩散加权 MRI 及其表观扩散系数鉴别多发性骨髓瘤的治疗反应深度:一项单中心研究的初步结果。
Acad Radiol. 2018 Jul;25(7):904-914. doi: 10.1016/j.acra.2017.12.008. Epub 2018 Jan 17.
8
Myeloma and Bone Disease.多发性骨髓瘤与骨病。
Curr Osteoporos Rep. 2017 Oct;15(5):483-498. doi: 10.1007/s11914-017-0397-5.
9
Myeloma bone disease: pathogenesis and treatment.骨髓瘤骨病:发病机制与治疗
Clin Adv Hematol Oncol. 2017 Apr;15(4):285-295.
10
Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.全身磁共振成像、动态对比增强磁共振成像及扩散加权成像在多发性骨髓瘤分期中的应用
Skeletal Radiol. 2017 Jun;46(6):733-750. doi: 10.1007/s00256-017-2609-6. Epub 2017 Mar 13.